The Analyst Landscape: 6 Takes On Sangamo Therapeutics
The Analyst Landscape: 6 Takes On Sangamo Therapeutics
分析师视角：对Sangamo Therapeutics的六个看法
The standing of Sangamo Therapeutics among...Analysts' ratings for Sangamo Therapeutics (NASDAQ:SGMO) over the last quarter vary from bullish to bearish, as provided by 6 analysts.
根据6位分析师的报告，Sangamo Therapeutics（纳斯达克：SGMO）在上个季度的分析师评级从看好到看淡不等。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他们近期评级的汇总视图，展示了过去30天的情绪变化，并将其与前几个月进行了比较。
Analysts have recently evaluated Sangamo Therapeutics and provided 12-month price targets. The average target is $8.17, accompanied by a high estimate of $10.00 and a low estimate of $5.00. Observing a 29.07% increase, the current average has risen from the previous average price target of $6.33.
分析师最近评估了Sangamo Therapeutics，并提供了12个月的价格目标。平均目标为8.17美元，最高预估为10.00美元，最低预估为5.00美元。观察到29.07%的增长，目前的平均值已从之前的6.33美元的平均价格目标上升。
Deciphering Analyst Ratings: An In-Depth Analysis
分析师评级解读：深入分析
The standing of Sangamo Therapeutics among...
通过对最近分...
登录免费看全文
登录/注册